LEGN Earnings & Financial Statements
Legend Biotech Corporation
$19.04
+$1.16(+6.49%)
52
Overall
55
Value
40
Tech
63
Quality
Market Cap
$3.70B
Volume
3.53M
52W Range
$16.24 - $37.50
Target Price
$47.82
LEGN earnings and financial statements: Legend Biotech Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
LEGN Annual Financial Statements
| Fiscal year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | $627.24M | $285.14M | $117.00M | $91.88M | $78.80M |
| Cost of revenue | $234.58M | $144.21M | -$65.36M | - | - |
| Operating income | -$136.52M | -$412.57M | -$364.96M | -$380.08M | -$226.43M |
| EBITDA | -$113.16M | -$477.87M | -$416.54M | - | -$298.16M |
| Net income | -$177.03M | -$521.98M | -$446.35M | -$386.21M | -$303.48M |
| EPS (diluted) | $-0.96 | $-1.47 | $-1.40 | $-2.74 | $-2.56 |
| Fiscal year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total assets | $1.67B | $1.85B | $1.33B | $953.40M | $670.62M |
| Total liabilities | $629.61M | $597.24M | $1.33B | $647.16M | $440.75M |
| Shareholders’ equity | $1.04B | $1.25B | $744.31M | $471.21M | $280.25M |
| Cash and equivalents | $286.75M | $1.28B | $786.03M | $858.61M | $506.07M |
| Long-term debt | $345.81M | $325.50M | $280.97M | $122.06M | $1.91M |
| Fiscal year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating cash flow | -$144.03M | -$393.28M | $244.44M | -$198.47M | -$223.00M |
| Capital expenditure | - | - | -$22.27M | -$47.11M | -$49.78M |
| Free cash flow | -$158.14M | -$514.78M | -$223.56M | -$198.47M | -$272.78M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LEGN | $19.04 | +6.5% | 3.53M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Legend Biotech Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW